None listed
Conditions
Interventions
Dietary Supplement : Red ginseng (KGC05P0) or Placebo
Tablets, 400mg/tablet, 2 Tablets/time, Twice a day, Oral administration for 12 weeks
Sponsors
Korea Ginseng Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Male or female adults aged 19 to 64 2) Participant who satisfies one of the followings; a. fasting blood glucose level between 100 and 125 mg/dL b. blood glucose level between 140 and 199 mg/dL with oral glucose tolerance test c. HbA1C level between 5.7 and 6.4% 3) Participants who voluntarily assent to participate in the study and sign the informed consents
Exclusion criteria
Exclusion criteria: 1) Participants taking hypoglycemic agents within 3 months 2) Patients diagnosed with thyroid diseases and under their treatments 3) Patients diagnosed with chronic gastrointestinal disorders 4) Uncontrolled hypertensive patients 5) Patients taking continuous treatments due to significantly glycometabolism-related disorders 6) Participants with 30kg/m2 or more of body mass index 7) Participants with renal dysfunction (1.5 times or more of upper limit of normal creatinine level), hepatic dysfunction (2.5 times or more of upper limits of normal alanine and aspartate aminotransferase levels), malignant tumors, or mental diseases 8) Participants who took any medications, herb medicines, or functional supplements for 3 days or more within 4 weeks 9) Pregnant or lactating females 10) Participants who took any surgeries due to significantly glycometabolism-related disorders within recent 6 months 11) Participants who have ever addicted to any drugs or alcohol 12) Participants who participated in other clinical studies within 1 month 13) Participants who are allergic or overreactive to the investigator’s product 14) Participants who are illiterate or cannot read written letters 15) Participants who have any other inappropriate reasons to participant in the study, judged by the investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oral Glucose Tolerance Test;Fasting glucose | — |
Secondary
| Measure | Time frame |
|---|---|
| blood insulin;C-peptide;Lipid profiles (triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, free fatty acid);Abdominal obesity index (waist circumference, waist hip ratio);HOMA-IR;Vital sign (systolic blood pressure, diastolic blood pressure, pulse rate);Labarotary test;Adverse events | — |
Countries
Korea, Republic of
Contacts
Public ContactEuiju Lee
Kyung Hee University Oriental Medical Center
Outcome results
None listed